Palmitate‐Stimulated Monocytes Induce Adhesion Molecule Expression in Endothelial Cells via IL‐1 Signaling Pathway

Increased intake of saturated fatty acids (SFAs), such as palmitate (Pal), is linked to a higher risk of type 2 diabetes and cardiovascular disease. Although recent studies have investigated the direct effects of SFAs on inflammatory responses in vascular endothelial cells, it remains unknown whether SFAs also induce these responses mediated by circulating cells. In this study, especially focused on adhesion molecules and monocytes, we investigated the indirect effects of Pal on expression and release of ICAM‐1 and E‐selectin in vascular endothelial cells. Phorbol 12‐myristate 13‐acetate (PMA)‐treated THP‐1 (pTHP‐1) cells and human monocytes were stimulated with various free fatty acids (FFAs). SFAs, but not unsaturated fatty acids (UFAs), increased interleukin (IL)‐1β secretion and decreased IL‐1 receptor antagonist (IL‐1Ra) secretion, resulting in an increase in the IL‐1β/IL‐1Ra secretion ratio. UFAs dose‐dependently inhibited the increase in IL‐1β secretion and decrease in IL‐1Ra secretion induced by Pal. Moreover, in human aortic and vein endothelial cells, expression and release of ICAM‐1 and E‐selectin were induced by treatment with conditioned medium collected from Pal‐stimulated pTHP‐1 cells and human monocytes, but not by Pal itself. The up‐regulated expression and release of adhesion molecules by the conditioned medium were mostly abolished by recombinant human IL‐1Ra supplementation. These results suggest that the Pal‐induced increase in the ratio of IL‐1β/IL‐1Ra secretion in monocytes up‐regulates endothelial adhesion molecules, which could enhance leukocyte adhesion to endothelium. This study provides further evidence that IL‐1β neutralization through receptor antagonism may be useful for preventing the onset and development of cardiovascular disease. J. Cell. Physiol. 230: 732–742, 2015. © 2014 Wiley Periodicals, Inc., A Wiley Company

[1]  H. Joller-jemelka,et al.  Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.

[2]  Han-Kyu Lee,et al.  Oleate prevents palmitate-induced mitochondrial dysfunction, insulin resistance and inflammatory signaling in neuronal cells. , 2014, Biochimica et biophysica acta.

[3]  L. Riva,et al.  Unsaturated fatty acids prevent activation of NLRP3 inflammasome in human monocytes/macrophages[S] , 2013, Journal of Lipid Research.

[4]  B. V. Van Tassell,et al.  Targeting interleukin-1 in heart disease. , 2013, Circulation.

[5]  J. Rutledge,et al.  Inflammasome-Mediated Secretion of IL-1β in Human Monocytes through TLR2 Activation; Modulation by Dietary Fatty Acids , 2013, The Journal of Immunology.

[6]  N. Ishimaru,et al.  Effects of Free Fatty Acids on Human Salivary Gland Epithelial Cells , 2013, Journal of dental research.

[7]  G. Owens,et al.  Genetic and Pharmacologic Disruption of Interleukin-1&bgr; Signaling Inhibits Experimental Aortic Aneurysm Formation , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[8]  A. Hasty,et al.  Stearic Acid Accumulation in Macrophages Induces Toll-Like Receptor 4/2-Independent Inflammation Leading to Endoplasmic Reticulum Stress–Mediated Apoptosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[9]  S. Kersten,et al.  Energy-sensing Factors Coactivator Peroxisome Proliferator-activated Receptor γ Coactivator 1-α (PGC-1α) and AMP-activated Protein Kinase Control Expression of Inflammatory Mediators in Liver , 2011, The Journal of Biological Chemistry.

[10]  F. Civeira,et al.  Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions. , 2011, Biochimica et biophysica acta.

[11]  G. Zaloga,et al.  Long-chain saturated fatty acids induce pro-inflammatory responses and impact endothelial cell growth. , 2010, Clinical nutrition.

[12]  Marc Daigneault,et al.  The Identification of Markers of Macrophage Differentiation in PMA-Stimulated THP-1 Cells and Monocyte-Derived Macrophages , 2010, PloS one.

[13]  F. Geissmann,et al.  Monocytes in atherosclerosis: subsets and functions , 2010, Nature Reviews Cardiology.

[14]  G. Moneta,et al.  Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .

[15]  J. Danesh,et al.  Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.

[16]  N. Samani,et al.  Saturated Fatty Acids Do Not Directly Stimulate Toll-Like Receptor Signaling , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[17]  F. Kim,et al.  Activation of NF-&kgr;B by Palmitate in Endothelial Cells: A Key Role for NADPH Oxidase-Derived Superoxide in Response to TLR4 Activation , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[18]  G. Lacraz,et al.  IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat , 2009, Proceedings of the National Academy of Sciences.

[19]  Walter C Willett,et al.  Dietary fats and prevention of type 2 diabetes. , 2009, Progress in lipid research.

[20]  B. Fielding,et al.  Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. , 2008, Progress in lipid research.

[21]  T. Hawn,et al.  Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity , 2007, Circulation research.

[22]  J. Pankow,et al.  Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study , 2006, Diabetologia.

[23]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[24]  P. Reaven,et al.  Elevated Concentrations of Nonesterified Fatty Acids Increase Monocyte Expression of CD11b and Adhesion to Endothelial Cells , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[25]  Barbara Thorand,et al.  Elevated Markers of Endothelial Dysfunction Predict Type 2 Diabetes Mellitus in Middle-Aged Men and Women From the General Population , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[26]  E. Trimble,et al.  Activation of peripheral blood CD14+ monocytes occurs in diabetes. , 2005, Diabetes.

[27]  F. Ohsuzu,et al.  Deficiency of Interleukin-1 Receptor Antagonist Deteriorates Fatty Liver and Cholesterol Metabolism in Hypercholesterolemic Mice* , 2005, Journal of Biological Chemistry.

[28]  T. Kadowaki,et al.  Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. , 2005, Endocrinology.

[29]  A. Bonen,et al.  A Novel Function for Fatty Acid Translocase (FAT)/CD36 , 2004, Journal of Biological Chemistry.

[30]  N. Takahashi,et al.  Probucol and ticlopidine: effect on platelet and monocyte activation markers in hyperlipidemic patients with and without type 2 diabetes. , 2004, Atherosclerosis.

[31]  H. Aburatani,et al.  A comparison of differences in the gene expression profiles of phorbol 12-myristate 13-acetate differentiated THP-1 cells and human monocyte-derived macrophage. , 2004, Journal of atherosclerosis and thrombosis.

[32]  Bing‐Bing Yang,et al.  Pharmacokinetics of anakinra in subjects with different levels of renal function , 2003, Clinical pharmacology and therapeutics.

[33]  E. Boerwinkle,et al.  Interaction Between Soluble Thrombomodulin and Intercellular Adhesion Molecule-1 in Predicting Risk of Coronary Heart Disease , 2003, Circulation.

[34]  M. Seishima,et al.  Lack of Interleukin-1&bgr; Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[35]  M. Babina,et al.  All‐trans retinoic acid down‐regulates expression and function of β2 integrins by human monocytes: opposite effects on monocytic cell lines , 2003, European journal of immunology.

[36]  T. V. van Berkel,et al.  Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential , 2003, Pharmacological Reviews.

[37]  W. Arend The balance between IL-1 and IL-1Ra in disease. , 2002, Cytokine & growth factor reviews.

[38]  M. Sampson,et al.  Monocyte and Neutrophil Adhesion Molecule Expression During Acute Hyperglycemia and After Antioxidant Treatment in Type 2 Diabetes and Control Patients , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[39]  H. Joller-jemelka,et al.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. , 2002, The Journal of clinical investigation.

[40]  E. Boerwinkle,et al.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. , 1997, Circulation.

[41]  A. Baron,et al.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. , 1997, The Journal of clinical investigation.

[42]  E. Eschwège,et al.  The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study , 1997, Diabetologia.

[43]  N. Hoogerbrugge,et al.  Hypertriglyceridemia Enhances Monocyte Binding to Endothelial Cells in NIDDM , 1996, Diabetes Care.

[44]  U. Ikeda,et al.  Monocyte-endothelial cell interaction induces expression of adhesion molecules on human umbilical cord endothelial cells. , 1996, Cardiovascular research.

[45]  P. Brandtzaeg,et al.  Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. , 1996, Journal of immunology.

[46]  M. Alessio,et al.  Synthesis, Processing, and Intracellular Transport of CD36 during Monocytic Differentiation (*) , 1996, The Journal of Biological Chemistry.

[47]  D. Waters,et al.  Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. , 1995, Circulation.

[48]  A. Kleinfeld,et al.  Unbound free fatty acid levels in human serum. , 1995, Journal of lipid research.

[49]  A. Koch,et al.  Intercellular adhesion molecule‐1 (ICAM‐1) expression and soluble ICAM‐1 (sICAM‐1) production by cytokine‐activated human aortic endothelial cells: a possible role for ICAM‐1 and sICAM‐1 in atherosclerotic aortic aneurysms , 1994, Clinical and experimental immunology.

[50]  K. Vaddi,et al.  Comparison of biological responses of human monocytes and THP‐1 cells to chemokines of the intercrine‐β family , 1994, Journal of leukocyte biology.

[51]  T. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm , 1994, Cell.

[52]  J. Neefjes,et al.  E-selectin and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro. , 1992, Immunology.

[53]  W. Arend,et al.  IL-1 receptor antagonist and IL-1 beta production in human monocytes are regulated differently. , 1991, Journal of immunology.

[54]  C. Dinarello,et al.  Production of interleukin-1 receptor antagonist and interleukin-1 beta by peripheral blood mononuclear cells is differentially regulated. , 1991, Blood.

[55]  C. Avnstorp,et al.  Interleukin‐1 , 1987 .